From genetically engineered rice cells, scientists have produced human beta-glucocerebrosidase (GCase) — the enzyme deficient in…
Ana Pena, PhD
Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
The case of a young women with Gaucher disease type 3, …
A case report on three family members with Gaucher disease (GD)…
Computational Analysis Identifies Mutation That May Be Targeted in Gaucher, Parkinson’s Diseases
A computational analysis added insight on the molecular effects of mutations linking Gaucher disease (GD) and susceptibility…
Simple algorithms and rapid tools such as dried blood spot assays can help speed diagnosis, avoid unnecessary biopsies,…
A generic version of Zavesca (miglustat) — a…
A woman with type 1 Gaucher disease had several potentially light-threatening blood vessel bulges called aneurysms in her brain,…
Keeping tabs on Gaucher patients’ blood glucosylsphingosine (GlcSph) levels could be an alternate way to keep…
Two Cerdelga (eliglustat) pills a day are slightly better than one pill a day of the same strength…